Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy ; volume:19 ; number:1 ; day:21 ; month:4 ; year:2020 ; pages:1-9 ; date:12.2020
Malaria journal ; 19, Heft 1 (21.4.2020), 1-9, 12.2020
- Classification
-
Medizin, Gesundheit
- Creator
-
Mwaiswelo, Richard
Ngasala, Bill
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-020-03235-3
- URN
-
urn:nbn:de:101:1-2020070301025724408226
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mwaiswelo, Richard
- Ngasala, Bill
- SpringerLink (Online service)
Other Objects (12)
Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy
Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians